Navigation Links
Bio-Optronics Incorporates RxPaying(TM) Patient Stipend Debit Card Feature in Clinical Conductor(TM) Clinical Trial Management System (CTMS)
Date:4/21/2009

ROCHESTER, N.Y., April 21 /PRNewswire/ -- Bio-Optronics, Inc. will enhance its Clinical Conductor(TM) Clinical Trial Management System with click-through integration to Interspond's RxPaying(TM) debit card solution. This offers a patient stipend payment alternative which improves efficiency and increases patient satisfaction. Clinical Conductor(TM) CTMS provides natural points in clinical trial workflow into which best-in-class tools and expertise can be integrated seamlessly. Dan Kerpelman, President and CEO states, "We are pleased to be integrating RxPaying(TM) debit cards as an efficient alternative to the patient stipend payment process and will continue to leverage Clinical Conductor(TM) as the entry point for seamless integration to tools that optimize efficiency, productivity, and improve collaboration across the clinical environment."

Clinical Conductor(TM) CTMS, proven to improve site efficiency and productivity, handles the complete enterprise workflow, from business development, to patient databases, recruitment, scheduling, workload planning, finances, and complete oversight and reporting, and provides an innovative Electronic Data Capture option. The academic medical center clinical trial management system solution adds research administration capabilities and custom interfaces to hospital enterprise systems.

The Rx Paying(TM) Debit Card helps ensure higher patient participation and retention by providing immediate access to their funds, which can be used to purchase items, request cash back from a purchase or get cash from an ATM. It centralizes the process of patient reimbursement for clinical studies as a whole. "Integrating RxPaying(TM) with Clinical Conductor(TM), one of the leading CTMS in the industry, is a natural fit and we are excited about our partnership. While both products are excellent stand-alone systems, the integration creates a more dynamic product by eliminating redundancy and streamlining the reimbursement process," according to Kathy S. Cox, President & CEO of Interspond.

Bio-Optronics, Inc. develops, deploys, and operates software products and custom information technology solutions to help healthcare professionals manage and optimize workflow, thus enhancing quality, productivity, and patient and staff satisfaction. For over 20 years, Bio-Optronics has demonstrated leadership in innovation, expertise in workflow and integration, and a singular approach to unparalleled customer service. Our workflow solutions are used in over 30 Veterans' Administration and other hospitals in the U.S., and over 400 clinical research sites around the world. www.bio-optronics.com

Interspond is a Trial Management Organization (TMO) for the pharmaceutical and biotechnology industries working to identify study opportunities for sites' participation. We maintain a database of hundreds of qualified, experienced investigative sites capable of conducting Phase I through Phase IV studies. These sites are located throughout the country and are multi-therapeutic in nature. Our RxPaying(TM) service offers electronic reimbursement for the clinical research industry. RxPaying(TM) streamlines and simplifies the process of reimbursing patients for participation in clinical research studies through the use of an instant issue debit card. www.interspond.com

CONTACT: Bio-Optronics, (877) 279-8377, www.bio-optronics.com; Maria Durkin, VP, Director Marketing and Operations, mdurkin@bio-optronics.com


'/>"/>
SOURCE Bio-Optronics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Health Management Corporation Incorporates Clinically Proven Care Diabetes Management Program With Programming From dLife
2. ASA plus clopidogrel reduces heart attack risk in patients with acute coronary syndrome
3. First Patients in United States Receive Innovative Device to Treat Moderate Heart Failure
4. Surveyed Specialists Foresee Greater Use of Parenteral Outpatient Therapy for the Treatment of Osteomyelitis
5. WakeMed Shares Best Practices for Tracking Assets, Patients
6. Tragic choices: Is it better for doctors or patient families to decide?
7. Thomson Reuters Study Finds More Patients Postponing Medical Care Due to Cost
8. Genetic variants predict recurrence of bladder cancer, patient survival
9. Acupuncture eases radiation-induced dry mouth in cancer patients
10. Doctor-Patient Talks Key to Blacks Getting Cancer Screens
11. PatientCentral Technologies, LLC and VerdaSee Solutions, Inc. Team Up With Congressional Staff in Washington, DC for Disaster Preparedness
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
(Date:6/24/2016)... Angeles, CA (PRWEB) , ... June 24, 2016 , ... ... surgery procedures that most people are unfamiliar with. The article goes on to state ... procedures, but also many of these less common operations such as calf and cheek ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary ... Dallas that it will receive two significant new grants to support its work ... marked its 25th anniversary by recognizing patients, medical professionals and scientists for their ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain ... for a minimum wage raise to $12 an hour by 2020 and then adjusting it ... the lost value of the minimum wage, assure the wage floor does not erode again, ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated testing ... With this clearance, Roche is the first IVD company ... for sepsis risk assessment and management. PCT ... PCT levels in blood can aid clinicians in assessing ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: